Prolepha Research B.V. is one of the fastest growing generic pharmaceutical companies in the Netherlands. We sell own label prescription only medication and next to that provide tailor made distribution solutions to companies seeking to successfully and swiftly penetrate the Dutch market with their pharmaceutical products. We have a proven track record in sales of both retail products (prescription only and OTC) and hospital products. Currently we sell a rapidly growing portfolio of prescription only medicines. Our products cover a wide range of therapeutic indication areas. We sell products through health insurance company tenders as well as via the traditional pharmacy segment.

World-wide out-licensing of generic CTD-format dossiers through marketing authorization agreements and interconnected supply agreements. The available dossiers cover all major therapeutic categories.

Glenmark Generics B.V. is a rapidly growing supplier of generic medicines in the Netherlands. This is secured by a robust and competitive pipeline of products along with a fast developing portfolio of niche generics. Cost effective production is secured by vertical integration. Glenmark has nationwide access to pharmacies and wholesalers and operates both across the tender and traditional pharmacy segments. The Dutch business is committed to providing the market with excellent service and bringing new innovations to the market. Prolepha provides Glenmark with local management for their Dutch business.

Responsible for general managerial affairs within Accord Healthcare B.V. Accord Healthcare is the sales/marketing formula of India based Intas Pharmaceuticals Ltd. Accord's global matrix spreads to Canada, USA, Mexico, Brasil, UK, Germany, France, Italy, Netherlands, South Africa, Australia etcetera.